SOUTH JORDAN, Utah, Jan. 07, 2019 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate at the 21stAnnual Needham […]
Other News
Phase 3 Trial of Mesoblast’s Cell Therapy in Chronic Heart Failure Completes Recruitment
NEW YORK and MELBOURNE, Australia, Jan. 07, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), world leader in development and commercialization of allogeneic (off-the-shelf) cellular medicines, today announced that it has completed patient recruitment in the events-driven Phase 3 trial of its product candidate Revascor (MPC-150-IM) for advanced chronic heart failure. Mesoblast Chief […]
REVA Expands Geographic Footprint to Seven New Countries
SAN DIEGO, Jan. 07, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced the geographic expansion of its commercial operations in seven European countries with the addition of four new distribution partnerships. These partnerships will allow […]
CES 2019: Omron Healthcare Launches First Wearable Blood Pressure Monitor, Previews Breakthrough Monitor with EKG and New Digital Health Services
LAS VEGAS, Jan. 7, 2019 /PRNewswire/ — Omron Healthcare is advancing its mission of Going for Zero™ heart attacks and strokes with breakthrough new heart health technology offerings at the 2019 Consumer Electronics Show (CES). The global market leader of personal heart health and wellness technology is launching its highly-anticipated HeartGuide, the first […]
JC Medical Announces First United States Treatment with the J-Valve TAVR Device
BURLINGAME, Calif.–(BUSINESS WIRE)–JC Medical today announced the successful treatment of the first U.S. patient with the company’s first-of-its-kind transfemoral TAVR device, the J-Valve TF System. The patient was treated at The Christ Hospital – Cincinnati, Ohio by Dean Kereiakes, MD, FACC, FSCAI, Medical Co-Director of the Lindner Research Center, working […]
ViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2018 Results
CLEVELAND, Jan. 7, 2019 /PRNewswire/ — ViewRay, Inc. (Nasdaq: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2018. The preliminary results have not been audited and are subject to change. Selected Fourth Quarter and Full Year 2018 Preliminary Highlights: Recognized 3 revenue units and 1 system upgrade […]
Access Scientific announces the first non-coated intravascular catheter material–ChronoFlex®C with BioGUARD™–proven in vitro to inhibit bacterial attachment and biofilm formation
SAN DIEGO, Jan. 7, 2019 /PRNewswire/ — Access Scientific, LLC today announced publication, in the journal Medical Devices: Evidence & Research, of a groundbreaking study proving the superiority of POWERWAND™ catheter material, Chronoflex®C with BioGUARD™ (as compared with the standard polyurethane) with respect to bacterial attachment and biofilm formation. Utilizing state-of-the-art fluorescent microscopy, the […]
Shockwave Announces Appointment of Ray Larkin as Chairman of the Board
SANTA CLARA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) — Shockwave Medical (“Shockwave”), a pioneer in the development and commercialization of intravascular lithotripsy to treat complex calcified cardiovascular disease, today announced that its Board of Directors has appointed Ray Larkin Jr. to join its Board of Directors and to serve as […]
Esperion Announces Agreement with Daiichi Sankyo Europe (DSE) to Commercialize Bempedoic Acid in Europe
ANN ARBOR, Mich., Jan. 04, 2019 (GLOBE NEWSWIRE) — Esperion Therapeutics (NASDAQ: ESPR) today announced that they have entered into a licensing agreement with Daiichi Sankyo Europe (DSE) providing DSE with exclusive rights to commercialize bempedoic acid and the bempedoic acid / ezetimibe combination pill in the European Economic Area […]
Leigh Elkolli Promoted to Chief Financial Officer at REVA Medical
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced the promotion of Leigh Elkolli to the position of Chief Financial Officer and Corporate Secretary, effective January 4, 2019. She will replace Brandi […]
Recent
Popular
- No commented posts yet